We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPS27A is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
1331.5
Number of samples
349
Samples
Sample
Description
TPM
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
4326.7
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
3471.8
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
3176.4
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
3162.9
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
3062.4
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
2895.9
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
2709.6
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
2596.8
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
2593.2
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
2570.0
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
2533.3
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
2500.2
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
2479.2
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
2391.1
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
2390.1
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
2374.3
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
2365.6
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
2350.8
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
2348.4
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
2321.0
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
2296.6
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
2289.4
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
2288.2
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
2281.3
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
2278.0
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
2272.7
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
2269.0
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
2250.4
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
2225.6
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
2201.2
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
2187.9
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
2155.0
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
2150.6
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
2100.5
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
2073.0
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
2043.3
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
2023.7
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
2007.5
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
1996.3
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
1986.7
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
1978.7
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
1968.7
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
1968.2
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
1963.9
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
1961.9
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
1953.1
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
1953.1
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
1945.3
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
1919.9
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
1908.4
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
1904.4
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
1899.4
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
1892.3
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
1883.1
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
1880.7
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
1877.9
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
1874.2
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
1861.4
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
1849.7
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
1848.4
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
1834.6
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
1832.7
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
1830.9
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
1822.8
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
1817.6
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
1814.0
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
1809.7
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
1808.3
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
1786.3
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
1786.1
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
1776.9
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
1772.3
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
1759.3
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
1756.5
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
1752.1
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
1744.9
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
1732.7
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
1732.3
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
1724.1
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
1706.6
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
1700.6
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
1700.5
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
1696.3
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
1692.5
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
1688.0
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
1657.7
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
1642.6
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
1639.7
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
1638.1
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
1628.2
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
1626.9
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
1619.8
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
1613.8
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
1597.1
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
1593.0
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
1589.7
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
1588.8
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
1569.6
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
1563.8
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
1548.1
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
1545.3
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
1538.6
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
1535.8
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
1527.6
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
1525.8
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
1525.3
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
1522.4
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
1518.5
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
1518.3
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
1514.7
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
1514.6
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
1507.8
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
1501.6
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
1488.6
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
1482.7
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
1475.2
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
1474.1
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
1466.9
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
1461.7
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
1460.8
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
1452.0
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
1447.2
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
1446.1
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
1444.3
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
1438.4
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
1438.3
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
1432.5
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
1431.8
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
1421.4
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
1417.3
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
1411.9
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
1410.7
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
1410.2
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
1408.9
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
1401.6
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
1401.5
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
1398.7
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
1397.9
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
1397.8
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
1385.4
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
1379.0
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
1376.3
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
1370.9
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
1369.6
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
1364.2
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
1363.6
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
1358.7
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
1353.3
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
1351.1
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
1345.6
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
1344.1
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
1341.8
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
1341.1
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
1336.8
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
1334.0
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
1330.2
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
1327.8
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
1325.0
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
1319.9
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
1318.3
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
1315.1
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
1307.6
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
1305.7
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
1301.0
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
1298.8
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
1297.6
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
1296.0
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
1292.4
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
1291.5
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
1283.9
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
1282.3
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
1275.0
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
1262.3
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
1258.1
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
1256.5
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
1253.6
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
1244.5
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
1241.8
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
1241.1
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
1240.1
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
1232.6
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
1227.2
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
1222.6
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
1220.0
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
1219.0
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
1208.4
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
1205.0
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
1204.5
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
1188.9
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
1173.9
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
1166.6
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
1160.0
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
1159.6
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
1159.0
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
1143.6
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
1140.8
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
1135.9
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
1126.9
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
1125.8
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
1124.7
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
1123.7
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
1115.1
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
1110.3
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
1106.6
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
1095.8
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
1087.2
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
1083.2
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
1081.7
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
1080.1
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
1070.8
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
1065.6
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
1065.2
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
1064.1
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
1058.1
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
1056.6
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
1051.5
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
1049.1
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
1041.5
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
1034.5
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
1031.6
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
1024.6
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
1021.1
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
1010.7
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
1008.6
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
1008.2
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
1004.6
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
1004.1
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
1002.4
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
1001.5
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
998.8
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
994.1
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
988.3
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
978.1
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
977.4
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
977.1
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
976.7
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
972.5
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
967.7
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
966.6
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
965.6
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
964.9
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
962.7
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
958.8
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
957.4
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
950.1
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
942.5
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
941.0
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
940.8
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
939.7
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
936.8
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
933.9
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
931.0
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
926.1
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
925.3
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
922.9
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
921.8
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
918.2
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
917.4
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
912.8
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
909.2
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
907.6
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
905.6
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
902.9
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
901.5
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
900.0
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
898.3
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
884.2
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
876.8
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
875.3
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
874.1
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
867.9
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
867.3
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
864.9
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
864.3
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
853.5
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
852.1
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
850.5
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
849.9
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
846.2
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
841.1
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
836.5
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
834.2
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
828.6
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
814.3
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
807.3
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
805.4
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
804.3
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
803.2
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
800.3
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
797.0
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
796.1
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
786.8
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
785.7
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
783.7
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
775.1
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
774.3
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
772.0
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
769.8
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
768.1
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
761.3
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
759.2
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
757.7
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
749.3
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
746.2
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
737.7
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
736.8
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
735.3
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
735.2
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
728.0
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
723.1
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
721.1
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
720.2
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
716.2
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
714.2
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
713.1
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
708.3
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
706.4
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
702.5
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
699.2
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
696.9
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
695.3
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
687.7
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
687.3
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
684.6
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
684.0
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
678.4
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
675.1
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
670.5
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
654.6
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
654.6
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
652.3
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
642.6
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
633.7
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
632.4
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
625.0
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
617.3
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
607.7
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
606.6
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
593.1
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
580.0
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
578.0
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
574.8
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
562.1
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
560.9
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
560.4
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
524.7
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
517.2
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
508.1
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPS27A is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
2500.3
Number of samples
81
Samples
Sample
Description
TPM
DO46328
0 years, female, NA, stage:III, dead, 972 days
8917.3
DO46390
0 years, female, NA, stage:III, dead, 374 days
8080.6
DO46356
0 years, female, NA, stage:III, dead, 911 days
6487.1
DO46591
0 years, female, NA, stage:III, dead, 195 days
4825.3
DO46384
0 years, female, NA, stage:III, dead, 614 days
4510.8
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
4501.1
DO46402
0 years, female, NA, stage:III, dead, 511 days
4185.0
DO46333
0 years, female, NA, stage:III, dead, 359 days
4100.9
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
4099.3
DO46338
0 years, female, NA, stage:III, dead, 596 days
3874.2
DO46568
0 years, female, NA, stage:III, dead, 320 days
3667.2
DO46370
0 years, female, NA, stage:III, dead, 1727 days
3541.4
DO46432
0 years, female, NA, stage:III, alive, 2218 days
3483.1
DO46586
0 years, female, NA, stage:III, dead, 1019 days
3417.8
DO46463
0 years, female, NA, stage:III, dead, 2451 days
3401.6
DO46518
0 years, female, NA, stage:III, alive, 2960 days
3273.5
DO46358
0 years, female, NA, stage:III, dead, 423 days
3264.7
DO46581
0 years, female, NA, stage:III, dead, 408 days
2971.5
DO46404
0 years, female, NA, stage:III, dead, 690 days
2959.9
DO46352
0 years, female, NA, stage:III, dead, 677 days
2938.1
DO46326
0 years, female, NA, stage:III, dead, 701 days
2858.5
DO46342
0 years, female, NA, stage:III, dead, 1398 days
2840.7
DO46336
0 years, female, NA, stage:IV, dead, 664 days
2830.0
DO46576
0 years, female, NA, stage:III, alive, 133 days
2815.7
DO46386
0 years, female, NA, stage:III, dead, 1162 days
2769.3
DO46334
0 years, female, NA, stage:III, dead, 496 days
2731.9
DO46392
0 years, female, NA, stage:III, dead, 628 days
2716.1
DO46561
0 years, female, NA, stage:III, dead, 195 days
2682.4
DO46380
0 years, female, NA, stage:III, dead, 1423 days
2678.2
DO46366
0 years, female, NA, stage:III, dead, 2054 days
2674.6
DO46388
0 years, female, NA, stage:III, dead, 413 days
2646.7
DO46350
0 years, female, NA, stage:III, dead, 886 days
2597.2
DO46364
0 years, female, NA, stage:III, dead, 806 days
2596.6
DO46330
0 years, female, NA, stage:III, dead, 684 days
2434.1
DO46588
0 years, female, NA, stage:III, dead, 438 days
2399.1
DO46400
0 years, female, NA, stage:III, dead, 719 days
2271.4
DO46560
0 years, female, NA, stage:IV, dead, 286 days
2254.3
DO46436
0 years, female, NA, stage:III, alive, 3193 days
2246.6
DO46346
0 years, female, NA, stage:III, dead, 1187 days
2242.3
DO46443
0 years, female, NA, stage:III, dead, 2464 days
2228.1
DO46362
0 years, female, NA, stage:III, dead, 1639 days
2208.2
DO46398
0 years, female, NA, stage:III, alive, 437 days
2178.7
DO46348
0 years, female, NA, stage:IV, dead, 287 days
2152.0
DO46372
0 years, female, NA, stage:III, dead, 1326 days
2151.1
DO46325
0 years, female, NA, stage:III, dead, 477 days
2122.3
DO46368
0 years, female, NA, stage:III, dead, 2879 days
2066.5
DO46566
0 years, female, NA, stage:III, dead, 673 days
2062.6
DO46597
0 years, female, NA, stage:III, dead, 393 days
2046.0
DO46508
0 years, female, NA, stage:III, dead, 2101 days
2014.7
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
1994.2
DO46611
0 years, female, NA, stage:III, dead, 734 days
1993.1
DO46528
0 years, female, NA, stage:III, alive, 6139 days
1923.1
DO46378
0 years, female, NA, stage:III, alive, 843 days
1893.1
DO46551
0 years, female, NA, stage:III, dead, 1055 days
1883.1
DO46533
0 years, female, NA, stage:III, alive, 3667 days
1870.2
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
1866.1
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
1786.9
DO46412
0 years, female, NA, stage:III, dead, 597 days
1733.8
DO46606
0 years, female, NA, stage:III, alive, 804 days
1695.7
DO46376
0 years, female, NA, stage:III, dead, 1430 days
1649.6
DO46408
0 years, female, NA, stage:III, dead, 489 days
1594.0
DO46344
0 years, female, NA, stage:III, dead, 642 days
1555.0
DO46453
0 years, female, NA, stage:III, dead, 3294 days
1543.2
DO46602
0 years, female, NA, stage:III, dead, 205 days
1504.8
DO46448
0 years, female, NA, stage:III, dead, 654 days
1498.4
DO46396
0 years, female, NA, stage:III, dead, 583 days
1476.3
DO46354
0 years, female, NA, stage:III, dead, 843 days
1413.2
DO46382
0 years, female, NA, stage:IV, dead, 311 days
1393.8
DO46468
0 years, female, NA, stage:III, alive, 2776 days
1389.1
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
1382.4
DO46340
0 years, female, NA, stage:III, dead, 616 days
1296.6
DO46327
0 years, female, NA, stage:III, dead, 184 days
1264.4
DO46374
0 years, female, NA, stage:III, dead, 1409 days
1247.1
DO46329
0 years, female, NA, stage:III, dead, 1699 days
1094.0
DO46571
0 years, female, NA, stage:III, dead, 243 days
962.7
DO46331
0 years, female, NA, stage:III, dead, 612 days
923.1
DO46546
0 years, female, NA, stage:III, dead, 1889 days
875.0
DO46493
0 years, female, NA, stage:IV, alive, 839 days
832.8
DO46332
0 years, female, NA, stage:III, dead, 689 days
799.6
DO46538
0 years, female, NA, stage:III, dead, 1527 days
590.8
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
587.2
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
1.9
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
1.8
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
1.7
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
1.5
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
1.4
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
1.4
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
1.4
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
1.4
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
1.4
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
1.3
1772e913-f62e-446a-8cf3-720348_D2
Tumor
1.3
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
1.3
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
1.3
e9d416e7-f661-400a-896e-388545_D2
Tumor
1.2
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
1.2
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
1.2
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
1.2
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
1.1
285fed94-1495-448e-879b-b55de9_D2
Tumor
1.1
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
1.1
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
1.1
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
1.1
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
1.0
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
1.0
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
1.0
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
1.0
2f901c90-617e-46da-9fac-d68369_D2
Tumor
1.0
15524912-685a-47ce-a824-567848_D2
Tumor
1.0
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
1.0
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
1.0
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
1.0
10c2d629-0287-4511-ac25-f29031_D2
Tumor
1.0
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
1.0
1a10c200-3895-4648-b951-94f99f_D2
Tumor
1.0
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
1.0
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
1.0
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
1.0
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
1.0
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
1.0
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.9
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.9
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.9
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.9
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.9
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.9
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.9
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.9
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.9
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.8
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.8
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.8
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.8
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.8
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.8
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.8
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.8
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
0.7
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.7
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.7
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.7
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
0.7
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.7
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.6
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.6
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
0.6
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.6
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
0.6
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.5
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.5
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
0.5
a3a26070-fb84-406a-8280-d555e6_D2
Normal
0.5
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.5
a65d8e76-640f-4341-a561-afbb57_D2
Normal
0.5
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.5
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
0.5
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.5
1db5574d-aca7-403c-8100-6e705f_D2
Normal
0.5
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
0.5
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.5
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.5
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.5
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.4
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
0.4
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.4
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
0.4
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
0.4
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
0.4
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
0.4
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
0.3
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.3
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
0.3
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
0.3
21efd60f-6a31-4b98-9477-16a905_D2
Normal
0.3
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.3
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.3
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
0.2
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
0.2
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
0.2
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
0.1
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
0.1
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
0.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.1
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
0.1
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
0.0
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
0.0
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
0.0
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
0.0
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.1
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
